26 February 2018 | News
Two-day conference draws cardiac electrophysiology experts from across the globe
On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its fourth international symposium on complex arrhythmias, EPLive 2018.
EPLive is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex arrhythmias, a condition in which the heart beats with an irregular or abnormal rhythm.
This event draws leaders in the field of electrophysiology from across the globe and gives the opportunity to shape physician practices and expand the scope of electrophysiology treatment options available to all patients.
EPLive is designed to help attendees gain a better understanding of techniques used to treat atrial and ventricular arrhythmias, implant complex devices and extract malfunctioning devices.
EPLive consists of four sections: Atrial Fibrillation (A Fib) ablation, Ventricular Tachycardia (VT) ablation, Devices and New Technology.
The sessions consist of a combination of live and recorded cases from some of the world's premier centers.
Cases include procedures such as A Fib ablation, ventricular tachycardia (VT) ablation, epicardial and endocardial VT ablation, left atrial appendage closures, lead extraction and venoplasty.
EPLive will also feature new technology pioneered by physicians at TCAI.
The conference will also focus on a variety of objectives, including:
Evaluating techniques used to map and ablate atrial and ventricular arrhythmias
Identifying processes to reduce complications and promote safety measures for the patient during ablation of A Fib and ventricular arrhythmias
Applying interventional approaches learned in ablation of complex ventricular arrhythmias
Demonstrating an understanding of the latest evidence and guidelines in arrhythmia management and treatment with new technology
Applying interventional approaches that best utilize the new technologies demonstrated to maximize clinical outcomes.